The surgical specimen segment by type of examination is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type of Examination, End User and Country.” The North America histopathology services market is expected to reach US$ 13,902.74 million by 2028 from US$ 9,283.83 million in 2021; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report highlights trends prevailing in the North America histopathology services market and the factors driving market along with those that act as hindrances. 

The histopathology market for biologics is growing at an unprecedented rate owing to expansion of biologics pipeline, increase in manufacturing complexity, and shift in the focus of companies toward core activities. A significant boom has been witnessed in the manufacturing of biologics. There is pressing need of scaling up the production once novel technologies get approval from the domestics and international approving bodies.  The competition within the biopharmaceutical sector is becoming fierce with more biological products and biosimilars being introduced in the market. Biologics manufacturers strive to keep manufacturing costs low, deliver high-quality drugs, improve process efficiency, and accelerate market entry. Inputs from expert histopathologists have been playing a significant role in the understanding of tumor biology as well as in the pathogenic mechanism of various microorganisms. These findings and inferences are utilized by dedicated organizations offering histopathological services. According to the Food and Drug Administration, as of September 2019, there were more than 350 biologics commercially available in the US biopharmaceutical market. Clinical trials and drug discovery procedures of these drugs are based on intrinsic histopathological studies conducted using high-tech equipment, under expert supervision. Thus, the increasing number of biologic treatment in the pipeline that require histopathological interventions is propelling the growth of the North America histopathology services market. Further, the escalating incidence of chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, is a leading causes of mortalities and disabilities worldwide. Researchers and therapists are exploring therapies for treating these diseases; they conduct detailed histopathological analysis to understand the pathophysiology of these diseases for designing therapies, which is contributing to the histopathology services market growth in North America.

The COVID-19 pandemic has impacted every aspect of the diagnostics industry in North America, including histopathology. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Due to lockdowns enforced in many countries, the number of elective and cancer surgeries have reduced significantly. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 diagnosis. A rapid increase in the number of infected patients in the US and Canada is hampering the growth of the histopathology services market performance in the region.

The North America histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. Based on end user, the North America histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. Geographically, the North America histopathology services market can be sub-segmented into U.S., Mexico and Canada.

Sonic Healthcare Limited, Laboratory Corporation of America Holdings, TPL Path Labs, Cureline Global Translational CRO, Targos, Experimental Pathology Laboratories Inc (EPL) and CHARLES RIVER LABORATORIES, INC. are among the leading companies operating in the North America histopathology services market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com